跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19 条关于
“excitotoxicity”
全部
19
临床试验
8
药物
0
机构
0
资讯
11
11个月前
iQure Pharma Secures US Patent for First-in-Class CNS Drug iQ-007 Targeting Glutamate Excitotoxicity
去年
iQure Pharma Appoints Former UCB Chief Medical Officer Iris Loew-Friedrich as Clinical and R&D Advisor
去年
iQure Pharma's iQ-007 Shows Promise in Preclinical Development for Neurological Disorders
去年
International Research Team Secures $800,000 to Advance First Potentially Regenerative Multiple Sclerosis Treatment
去年
IFB-088 Shows Promise in Phase 2 Trial for Bulbar-Onset ALS, Demonstrating Slower Disease Progression
去年
GNT Pharma's Nelonemdaz Shows Promise in Improving Stroke Outcomes with Early Administration
9个月前
Shionogi Acquires RADICAVA Business from Tanabe Pharma for $2.5 Billion to Strengthen Rare Disease Portfolio
7个月前
Largest Metabolomic Study of CAR T-Cell Therapy Reveals New Biomarkers for Predicting Severe Neurotoxicity
9个月前
Phase 2 Trial Shows Promise for GLP-1 Receptor Agonists in Large Vessel Occlusion Stroke Treatment
上个月
Micot Pharma's MT200605 Hits Phase II Primary Endpoint in Acute Ischemic Stroke, Offering First-in-Class Multi-Stage Neuroprotection
第 1 页,共 2 页
上一页
下一页